Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives
Asthma is a chronic disease of airway inflammation with a large global burden. Despite established, guideline-based stepwise therapy, a significant proportion of patients remain symptomatic and poorly controlled. As such, there is a need for additional safe, effective, convenient, and cost-effective...
Saved in:
| Main Authors: | V. Madhu Chari, Robert Andrew McIvor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2018/3464960 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Efficacy of Tiotropium as a Steroid-Sparing Agent in Severe Asthma
by: Anmol S Kapoor, et al.
Published: (2009-01-01) -
Real-Life Asthma Care in Canada
by: RA McIvor, et al.
Published: (2009-01-01) -
Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma
by: Elizabeth Miller, et al.
Published: (2007-01-01) -
The Role of Omalizumab in the Treatment of Severe Allergic Asthma
by: Kenneth R Chapman, et al.
Published: (2006-01-01) -
Current views on the use of long-acting anticholinergic drug tiotropium in the treatment of bronchial asthma among children
by: E. V. Churyukina
Published: (2023-03-01)